Sutil, Evelyn T.
HRN: 21-50-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/24/2022
06/30/2022
IVT
4.5g
Q8
Xanthogranulomatous Pyelonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes